US Stock Movement | Replimune Rises Another 12% in Pre-market as Late-stage Melanoma Drug Application Sees Breakthrough
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Golden Ten Data June 1｜Last Friday (May 29), Replimune (REPL.US) soared 85.68%, and today it continues to rise by 12.54% in pre-market trading, reaching $9.78. In the latest news, Replimune stated in a declaration that it has "agreed on a path forward" with the U.S. Food and Drug Administration (FDA) and will resubmit its application for its late-stage melanoma treatment drug, with the FDA promising to treat this review as an "urgent matter." Previously, in April this year, the FDA rejected Replimune's combination therapy for late-stage melanoma for the second time.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
JPMorgan Chase: SpaceX Inclusion in Nasdaq 100 Index Could Trigger $4.3 Billion Passive Fund Inflows
BlockBeats•2026/06/27 09:54
Exchange leads you to trending coins: AAVE's popularity rises, up 11.53% in 24H
AiCoin•2026/06/27 09:33
NAVI Protocol incubates Premium Exchange ecosystem token PST, which will soon be launched
Chaincatcher•2026/06/27 09:16
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$60,307.76
+1.02%
Ethereum
ETH
$1,579.4
+1.69%
Tether USDt
USDT
$0.9985
-0.01%
USDC
USDC
$0.9997
+0.01%
XRP
XRP
$1.06
+2.51%
Solana
SOL
$71.67
+3.93%
TRON
TRX
$0.3205
-0.47%
Hyperliquid
HYPE
$62.76
-0.01%
Dogecoin
DOGE
$0.07522
+1.74%
Zcash
ZEC
$407.23
+1.61%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now